Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Klinika Rustavi | Clinic-LJ | National Center of Tube… | St. Michael the Archang… | Infectious Pathology, A… |
|---|---|---|---|---|---|
| Total Revenue | 16,726 | 15,596 | 15,540 | 15,261 | — |
| Total COGS | -3,439 | -11,307 | -15,171 | -4,160 | — |
| Gross Profit | 13,287 | 4,289 | 369 | 11,100 | — |
| Gross Margin | 79.4% | 27.5% | 2.4% | 72.7% | — |
| Total Operating Expenses | -11,139 | -2,872 | -3,002 | -16,605 | — |
| EBITDA | 2,148 | 1,417 | -2,633 | -4,194 | — |
| EBITDA Margin | 12.8% | 9.1% | -16.9% | -27.5% | — |
| Total D&A | -1,190 | 0 | -529 | -1,294 | — |
| EBIT / Operating Income | 958 | 1,417 | -3,162 | -5,488 | — |
| Total Interest Expense | -371 | — | -49 | -878 | — |
| Total Other Income | 147 | -276 | 251 | 263 | — |
| Profit Before Tax | 734 | 1,141 | -2,796 | -6,104 | — |
| Total Income Tax | 0 | -16 | 0 | 0 | — |
| Net Profit / (Loss) | 734 | 1,125 | -2,796 | -6,104 | — |
| Net Margin | 4.4% | 7.2% | -18.0% | -40.0% | — |
| Total Interest Income | — | — | 164 | — | — |
| Other Operating Income | — | — | — | 1,311 | — |
Not every picked company reports every selected year — FY2024: no filing for Infectious Pathology, A…. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Klinika Rustavi | Healthcare Services | 12.8% | 58th pct | 268 |
| Clinic-LJ | Healthcare Services | 9.1% | 48th pct | 268 |
| National Center of Tube… | Healthcare Services | -16.9% | 10th pct | 268 |
| St. Michael the Archang… | Healthcare Services | -27.5% | 6th pct | 268 |
| Infectious Pathology, A… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.